Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v1-EN
Language French English
Date Updated 2022-06-23 2019-03-04
Drug Identification Number 02458381 02458381
Brand name PMS-ABACAVIR-LAMIVUDINE PMS-ABACAVIR-LAMIVUDINE
Common or Proper name ABACAVIR/LAMIVUDINE ABACAVIR/LAMIVUDINE
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients ABACAVIR LAMIVUDINE ABACAVIR LAMIVUDINE
Strength(s) 600MG 300MG 600MG 300MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code J05AR J05AR
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2019-03-01 2019-03-01
Estimated end date 2022-04-25 2019-10-02
Actual end date 2022-06-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments